Krka, d. d. (KRK.WA)

PLN 590.0

(0.0%)

Market Cap (In PLN)

18.14 Billion

Revenue (In PLN)

1.8 Billion

Net Income (In PLN)

313.94 Million

Avg. Volume

96.00

Currency
PLN
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
474.0-660.0
PE
-
EPS
-
Beta Value
0.525
ISIN
SI0031102120
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Jože Colaric
Employee Count
-
Website
https://www.krka.biz
Ipo Date
2012-04-11
Details
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising antiinfectives, antiparasitics, and other products for farm and companion animals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.